Recombinant CCL2 (Carlumab Biosimilar) antibody

Catalog No. ABIN7538059

This anti-CCL2 (Carlumab Biosimilar) antibody is a Human Monoclonal antibody detecting CCL2 (Carlumab Biosimilar) in ELISA and WB. Suitable for Human.

Quick Overview for Recombinant CCL2 (Carlumab Biosimilar) antibody (ABIN7538059)

Target: CCL2 (Carlumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CCL2 (Carlumab Biosimilar) antibody is un-conjugated

Application: ELISA, Western Blotting (WB)

Grade: Research Grade

Product Details anti-CCL2 (Carlumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Carlumab Biosimilar – Anti-CCL2 mAb - Research Grade

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Purity: > 85%

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer PH7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for CCL2 (Carlumab Biosimilar)

Target: CCL2 (Carlumab Biosimilar)

Background: Carlumab is a human anti-CCL2 (chemokine ligand 2) antibody with high affinity. Carlumab can be used in cancer research, particularly in prostate cancer.

CAS-No: 915404-94-3